Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Yin, Hao, Song, Chun-Qing, Dorkin, Joseph R, Zhu, Lihua J, Li, Yingxiang, Wu, Qiongqiong, Park, Angela, Yang, Junghoon +14 more·2016·Nature Biotechnology

Cited by (874)

Items 101–200 of 874

  1. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
    Qiaoqiao Xiao, Deyin Guo, Shuliang Chen · 2019 · Frontiers in Cellular and Infection Microbiology
  2. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases
    Hyewon Jang, Dong Hyun Jo, Chang Sik Cho, Jeong Hong Shin, Jung Hwa Seo, Goosang Yu, Ramu Gopalappa, Daesik Kim, Sung‐Rae Cho, Jeong Hun Kim et al. · 2021 · Nature Biomedical Engineering
  3. Biodegradable Polymers for Gene-Delivery Applications
    Chih‐Kuang Chen, Ping-Kuan Huang, Wing‐Cheung Law, Chia-Hui Chu, Nai‐Tzu Chen, Leu‐Wei Lo · 2020 · International Journal of Nanomedicine
  4. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells
    Yangyang Ye, Xiang Zhang, Fei Xie, Bin Xu, Ping Xie, Ting Yang, Qian Shi, Chen‐Yu Zhang, Yujing Zhang, Jiangning Chen et al. · 2020 · Biomaterials Science
  5. CRISPR-Cas9-mediated homology-directed repair for precise gene editing
    Hongyu Liao, Jiahao Wu, Nathan J. VanDusen, Yifei Li, Yanjiang Zheng · 2024 · Molecular Therapy — Nucleic Acids
  6. Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
    Mohammed Fatih Rasul, Bashdar Mahmud Hussen, Abbas Burhan Salihi, Bnar Saleh Ismael, Paywast Jamal Jalal, Anna Zanichelli, Elena Jamali, Aria Baniahmad, Soudeh Ghafouri‐Fard, Abbas Basiri et al. · 2022 · Molecular Cancer
  7. CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
    Haiwei Mou, Jordan L. Smith, Lingtao Peng, Hao Yin, Jill E. Moore, Xiao-Ou Zhang, Chun‐Qing Song, Ankur Sheel, Qiongqiong Wu, Deniz Mahmut Özata et al. · 2017 · Genome biology
  8. CRISPR–Cas: a tool for cancer research and therapeutics
    Hao Yin, Wen Xue, Daniel G. Anderson · 2019 · Nature Reviews Clinical Oncology
  9. Gene Editing on Center Stage
    Rasmus Otkjær Bak, Natalia Gomez‐Ospina, Matthew Hebden Porteus · 2018 · Trends in Genetics
  10. Nanoscale platforms for messenger RNA delivery
    Li, Bin, Zhang, Xinfu, Dong, Yizhou · 2019 · WIREs Nanomedicine and Nanobiotechnology
  11. In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease
    Lau, Cia-Hin, Suh, Yousin · 2017 · F1000Research
  12. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation
    Moreno, Ana M., Fu, Xin, Zhu, Jie, Katrekar, Dhruva, Shih, Yu-Ru V., Marlett, John, Cabotaje, Jessica, Tat, Jasmine, Naughton, John, Lisowski, Leszek et al. · 2018 · Molecular Therapy
  13. Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
    Xuejiao Han, Aqu Alu, Hongmei Liu, Yi Shi, Xiawei Wei, Lulu Cai, Yuquan Wei · 2022 · Bioactive Materials
  14. Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
    David C. Luther, Y.W. Lee, Harini Nagaraj, Federica Scaletti, Vincent M. Rotello · 2018 · Expert Opinion on Drug Delivery
  15. Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome
    Kaitlin Mrksich, Marshall Scott Padilla, Michael J. Mitchell · 2024 · Advanced Drug Delivery Reviews
  16. Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
    Yasmin Granot-Matok, Dan Peer · 2017 · Seminars in Immunology
  17. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
    Fatima Rizvi, Elissa Everton, Anna R. Smith, Hua Liu, Elizabeth Osota, Mitchell B. Beattie, Ying K. Tam, Norbert Pardi, Drew Weissman, Valerie Gouon–Evans · 2021 · Nature Communications
  18. Spatial control of in vivo CRISPR–Cas9 genome editing via nanomagnets
    Haibao Zhu, Linlin Zhang, Sheng Tong, Ciaran M. Lee, Harshavardhan Deshmukh, Gang Bao · 2018 · Nature Biomedical Engineering
  19. Programmable base editing of mutated TERT promoter inhibits brain tumour growth
    Xinjian Li, Xu Qian, Bin Wang, Yan Xia, Yanhua Zheng, Linyong Du, Daqian Xu, Dongming Xing, Ronald Anthony DePinho, Zhimin Lu · 2020 · Nature Cell Biology
  20. Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing
    Yue, Huahua, Zhou, Xiaoming, Cheng, Meng, Xing, Da · 2018 · Nanoscale
  21. Genome-wide profiling of adenine base editor specificity by EndoV-seq
    Liang, Puping, Xie, Xiaowei, Zhi, Shengyao, Sun, Hongwei, Zhang, Xiya, Chen, Yu, Chen, Yuxi, Xiong, Yuanyan, Ma, Wenbin, Liu, Dan et al. · 2019 · Nature Communications
  22. Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xiaojie Xu, Tao Yu Wan, Huhu Xin, Da Li, Hongming Pan, Jun Wu, Ping Yuan · 2019 · The Journal of Gene Medicine
  23. A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo
    Khalid A. Hajj, Jilian R. Melamed, Namit Chaudhary, Nicholas G. Lamson, Rebecca L. Ball, Saigopalakrishna S. Yerneni, Kathryn A. Whitehead · 2020 · Nano Letters
  24. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo—Brief Report
    Xiao Wang, Avanthi Raghavan, Tao Chen, Lyon Qiao, Yongxian Zhang, Qiurong Ding, Kiran Musunuru · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
  25. Immunity to CRISPR Cas9 and Cas12a therapeutics
    Wei Leong Chew · 2017 · WIREs Systems Biology and Medicine
  26. A Proton‐Activatable DNA‐Based Nanosystem Enables Co‐Delivery of CRISPR/Cas9 and DNAzyme for Combined Gene Therapy
    Feng Li, Nachuan Song, Yuhang Dong, Shuai Li, Ling‐Hui Li, Yujie Liu, Zhemian Li, Dayong Yang · 2022 · Angewandte Chemie International Edition
  27. Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
    Radwa Ewaisha, Karen S. Anderson · 2023 · Frontiers in Bioengineering and Biotechnology
  28. CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
    Wei-Jing Dai, Liyao Zhu, Zhongyi Yan, Yong Xu, Qilong Wang, Xiaojie Lu · 2016 · Molecular Therapy — Nucleic Acids
  29. Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering
    Kunwoo Lee, Vanessa A Mackley, Anirudh Rao, Anthony T. Chong, Mark A. DeWitt, Jacob E. Corn, Niren Murthy · 2017 · eLife
  30. Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
    Yi Lin, Ernst Wagner, Ulrich Lächelt · 2022 · Biomaterials Science
  31. Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
    Sarah J. Shepherd, Xuexiang Han, Alvin J. Mukalel, Rakan D. El-Mayta, Ajay S. Thatte, Jingyu Wu, Marshall Scott Padilla, Mohamad‐Gabriel Alameh, Neha Srikumar, Daeyeon Lee et al. · 2023 · Proceedings of the National Academy of Sciences
  32. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
    Alvin J. Mukalel, Rachel Riley, Rui Zhang, Michael J. Mitchell · 2019 · Cancer Letters
  33. A Self-Assembled Platform Based on Branched DNA for sgRNA/Cas9/Antisense Delivery
    Jianbing Liu, Tiantian Wu, Xuehe Lu, Xiaohui Wu, Shaoli Liu, Shuai Zhao, Xuehui Xu, Baoquan Ding · 2019 · Journal of the American Chemical Society
  34. Ionizable Amino‐Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino‐Alcohols for Tissue Selective mRNA Delivery
    Piotr S. Kowalski, Umberto Capasso Palmiero, Yuxuan Huang, Arnab Rudra, Róbert Langer, Daniel G. Anderson · 2018 · Advanced Materials
  35. Long-lasting analgesia via targeted in situ repression of Na V 1.7 in mice
    Ana M. Moreno, Fernando Alemán, Glaucilene Ferreira Catroli, Matthew A. Hunt, Michael Y. Hu, Amir Dailamy, Andrew Pla, Sarah A. Woller, Nathan D. Palmer, Udit Parekh et al. · 2021 · Science Translational Medicine
  36. Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases
    Shaoshuai Wu, Qing-Cui Li, Changqing Yin, Wen Xue, Chun‐Qing Song · 2020 · Theranostics
  37. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
    Tuo Wei, Qiang Cheng, Lukas Farbiak, Daniel G. Anderson, Róbert Langer, Daniel J. Siegwart · 2020 · ACS Nano
  38. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery
    Luke H. Rhym, Rajith S. Manan, Antonius A. Koller, Georgina Stephanie, Daniel G. Anderson · 2023 · Nature Biomedical Engineering
  39. Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
    Colette Moses, Fiona Nugent, Charlene Babra Waryah, Benjamín García‐Bloj, Alan R. Harvey, Pilar Blancafort · 2018 · Molecular Therapy — Nucleic Acids
  40. Chitosan in Non-Viral Gene Delivery: Role of Structure, Characterization Methods, and Insights in Cancer and Rare Diseases Therapies
    Beatriz Santos-Carballal, Elena Fernández Fernández, Francisco M. Goycoolea · 2018 · Polymers
  41. Nanoplatforms for mRNA Therapeutics
    Meng, Chaoyang, Chen, Zhe, Li, Gang, Welte, Thomas, Shen, Haifa · 2021 · Advanced Therapeutics
  42. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer
    Yang Liu, Cong‐Fei Xu, Shoaib Iqbal, Xianzhu Yang, Jun Wang · 2017 · Advanced Drug Delivery Reviews
  43. CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine
    Filipe V. Jacinto, Wolfgang Link, Bibiana I. Ferreira · 2020 · Journal of Cellular and Molecular Medicine
  44. Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
    Mohadeseh Khoshandam, Hossein Soltaninejad, Marziyeh Mousazadeh, Amir Ali Hamidieh, Saman Hosseinkhani · 2023 · Genes & Diseases
  45. Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development
    Qian Chen, Zhen Yang, Haoyu Liu, Jingyuan Man, Ayodele Olaolu Oladejo, Sally Ibrahim, Shengyi Wang, Baocheng Hao · 2024 · Pharmaceutics
  46. Synthetic genetic circuits for programmable biological functionalities
    Peng‐Fei Xia, Hua Ling, Jee Loon Foo, Matthew Wook Chang · 2019 · Biotechnology Advances
  47. Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA
    Jessica A. Kretzmann, Diwei Ho, Cameron W. Evans, Janice H. C. Plani-Lam, Benjamín García‐Bloj, A. Elaaf Mohamed, Megan L. O’Mara, Ethan Ford, Dennis Eng Kiat Tan, Ryan Lister et al. · 2017 · Chemical Science
  48. CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges
    Marta Martínez-Lage, Pilar Puig-Serra, Pablo R. Menéndez, Raúl Torres-Ruiz, Sandra Rodríguez · 2018 · Biomedicines
  49. Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
    Tzu‐Chieh Ho, Hye Sung Kim, Yumei Chen, Yamin Li, Mark W. LaMere, Caroline Chen, Hui Wang, Jing Gong, Cal D. Palumbo, John M. Ashton et al. · 2021 · Science Advances
  50. Biomedical applications of mRNA nanomedicine
    Xiong, Qingqing, Lee, Gha Young, Ding, Jianxun, Li, Wenliang, Shi, Jinjun · 2018 · Nano Research
  51. The NIH Somatic Cell Genome Editing program
    Krishanu Saha, Erik J. Sontheimer, Philip John Brooks, Melinda R. Dwinell, Charles A. Gersbach, David R. Liu, Stephen A. Murray, Shengdar Q. Tsai, Ross C. Wilson, Daniel G. Anderson et al. · 2021 · Nature
  52. Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
    Dou Yu, Omar F. Khan, Mario L. Suvà, Biqin Dong, Wojciech K. Panek, Ting Xiao, Meijing Wu, Yu Han, Atique U. Ahmed, Irina V. Balyasnikova et al. · 2017 · Proceedings of the National Academy of Sciences
  53. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice
    Chun‐Qing Song, Yingxiang Li, Haiwei Mou, Jill E. Moore, Angela Park, Yotsawat Pomyen, Soren H. Hough, Zachary Kennedy, Andrew H. Fischer, Hao Yin et al. · 2016 · Gastroenterology
  54. Therapeutic gene editing: delivery and regulatory perspectives
    Gayong Shim, Dongyoon Kim, Gyu Thae Park, Hyerim Jin, Soo‐Kyung Suh, Yu‐Kyoung Oh · 2017 · Acta Pharmacologica Sinica
  55. mRNA therapeutics deliver a hopeful message
    Zifu Zhong, Séan Mc Cafferty, Francis Combes, Hanne Huysmans, Joyca De Temmerman, Arlieke Gitsels, Daisy C.G. Vanrompay, João Portela Catani, Niek N. Sanders · 2018 · Nano Today
  56. Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
    Chun‐Hao Huang, Ko-Chuan Lee, Jennifer A. Doudna · 2018 · Trends in cancer
  57. Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems
    Egor Egorov, Calvin Pieters, Hila Korach-Rechtman, Jeny Shklover, Avi Schroeder · 2021 · Drug Delivery and Translational Research
  58. Genome editing by natural and engineered CRISPR-associated nucleases
    Wen Y. Wu, Joyce H.G. Lebbink, Roland Kanaar, Niels Geijsen, John van der OOST · 2018 · Nature Chemical Biology
  59. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
    Rasmus Otkjær Bak, Matthew Hebden Porteus · 2017 · Cell Reports
  60. CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
    Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S.E. Cheah, Hung‐Fat Tse, Qizhou Lian · 2017 · Molecular Therapy — Nucleic Acids
  61. In vivo genome editing via the HITI method as a tool for gene therapy
    Keiichiro Suzuki, Juan Carlos Izpisúa Belmonte · 2017 · Journal of Human Genetics
  62. Non-Viral Delivery To Enable Genome Editing
    Yuan Rui, David R. Wilson, Jordan J. Green · 2018 · Trends in biotechnology
  63. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing
    Charlene Babra Waryah, Colette Moses, Mahira Arooj, Pilar Blancafort · 2018 · Methods in molecular biology
  64. CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation
    Wujin Sun, Jinqiang Wang, Quanyin Hu, Xingwu Zhou, Ali Khademhosseini, Zhen Gu · 2020 · Science Advances
  65. Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
    Samuel Lessard, Laurent C. Francioli, Jessica Alföldi, Jean‐Claude Tardif, Patrick T. Ellinor, Daniel G. MacArthur, Guillaume Lettre, Stuart H. Orkin, Matthew C. Canver · 2017 · Proceedings of the National Academy of Sciences
  66. Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
    Peng Guo, Jiang Yang, Jing Huang, Debra T. Auguste, Marsha A. Moses · 2019 · Proceedings of the National Academy of Sciences
  67. Non-viral delivery of genome-editing nucleases for gene therapy
    M Wang, Zachary Glass, Qiaobing Xu · 2016 · Gene Therapy
  68. Systemic delivery of CRISPR/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy
    Yang Liu, Gui Zhao, Cong‐Fei Xu, Ying‐Li Luo, Zi-Dong Lu, Jun Wang · 2018 · Biomaterials Science
  69. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo
    Raed Ibraheim, Chun‐Qing Song, Aamir Mir, Nadia Amrani, Wen Xue, Erik J. Sontheimer · 2018 · Genome biology
  70. Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
    Mike Broeders, Pablo Herrero-Hernandez, Martijn P. T. Ernst, Ans T. van der Ploeg, W.W.M. Pim Pijnappel · 2019 · iScience
  71. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope
    Tingting Jiang, Jordana M. Henderson, Kevin J. Coote, Yi Cheng, Hillary C. Valley, Xiao-Ou Zhang, Qin Wang, Luke H. Rhym, Yueying Cao, Gregory A. Newby et al. · 2020 · Nature Communications
  72. Cell-type-specific genome editing with a microRNA-responsive CRISPR–Cas9 switch
    Moe Hirosawa, Yoshihiko Fujita, Callum Parr, Karin Hayashi, Shunnichi Kashida, Akitsu Hotta, Knut Woltjen, Hirohide Saito · 2017 · Nucleic Acids Research
  73. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
    Hidefumi Mukai, Koki Ogawa, Naoya Kato, Shigeru Kawakami · 2022 · Drug Metabolism and Pharmacokinetics
  74. Biodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo
    Zhang, Xinfu, Li, Bin, Luo, Xiao, Zhao, Weiyu, Jiang, Justin, Zhang, Chengxiang, Gao, Min, Chen, Xiaofang, Dong, Yizhou · 2017 · ACS Applied Materials & Interfaces
  75. Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
    Liting You, Ruizhan Tong, Mengqian Li, Yuncong Liu, Jianxin Xue, You Lü · 2019 · Molecular Therapy — Methods & Clinical Development
  76. Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein
    Ran Chen, Hongxin Huang, Hui Liu, Jingyuan Xi, Jing Ning, Wanjia Zeng, Congle Shen, Ting Zhang, Guangxin Yu, Qiang Xu et al. · 2019 · Small
  77. CRISPR/Cas9 for Human Genome Engineering and Disease Research
    Xin Xiong, Meng Chen, Wendell A. Lim, Dehua Zhao, Lei S. Qi · 2016 · Annual Review of Genomics and Human Genetics
  78. CRISPR technologies for stem cell engineering and regenerative medicine
    Mu‐Nung Hsu, Yu‐Han Chang, Vu Anh Truong, Po‐Liang Lai, Thị Kieu Nuong Nguyen, Yu‐Chen Hu · 2019 · Biotechnology Advances
  79. In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles
    Yuyuan Wang, Pawan Kumar Shahi, Xiuxiu Wang, Ruosen Xie, Yi Zhao, Min Wu, Seth Roge, Bikash Ranjan Pattnaik, Shaoqin Gong · 2021 · Journal of Controlled Release
  80. Carrier strategies boost the application of CRISPR/Cas system in gene therapy
    Zunkai Xu, Qingnan Wang, Haiping Zhong, Yaoyao Jiang, Xiaoguang Shi, Bo Yuan, Na Yu, Shubiao Zhang, Xiaoyong Yuan, Shutao Guo et al. · 2022 · Exploration
  81. Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives
    Shainan Hora, Torsten Wüestefeld · 2023 · Cells
  82. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency
    Shaohua Lei, Junghyun Ryu, Ke Wen, Erica L. Twitchell, Tammy Bui, Ashwin Kumar Ramesh, Mariah Weiss, Guohua Li, Helen Samuel, Sherrie Clark‐Deener et al. · 2016 · Scientific Reports
  83. Nanostructured Materials for Intracellular Cargo Delivery
    Andy Kah Ping Tay, Nicholas A. Melosh · 2019 · Accounts of Chemical Research
  84. Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
    Haohao Yin, Liping Sun, Yinying Pu, Jifeng Yu, Wei Feng, Caihong Dong, Bangguo Zhou, Dou Du, Yan Zhang, Yu Chen et al. · 2021 · ACS Central Science
  85. CRISPR-Cas9–mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis
    Dong Hyun Jo, Dong Woo Song, Chang Sik Cho, Un Gi Kim, Kyu Jun Lee, Kihwang Lee, Sung Wook Park, Jin‐Soo Kim, Jin Hyoung Kim, Jin‐Soo Kim et al. · 2019 · Science Advances
  86. All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
    Lukas Farbiak, Qiang Cheng, Tuo Wei, Ester Álvarez‐Benedicto, Lindsay T. Johnson, Sang M. Lee, Daniel J. Siegwart · 2021 · Advanced Materials
  87. Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications
    Siddharth Patel, Avathamsa Athirasala, Paula dos Passos Menezes, N. Ashwanikumar, Ting Zou, Gaurav Sahay, Luiz E. Bertassoni · 2018 · Tissue Engineering Part A
  88. Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
    Keith Henry Moss, Petya G. Popova, Sine Reker Hadrup, Kira Astakhova, Maria Taskova · 2019 · Molecular Pharmaceutics
  89. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain
    Saed Abbasi, Satoshi Uchida, Kazuko Toh, Theofilus A. Tockary, Anjaneyulu Dirisala, Kotaro Hayashi, Shigeto Fukushima, Kazunori Kataoka · 2021 · Journal of Controlled Release
  90. Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease
    Kelsey E. Jarrett, Ciaran M. Lee, Yi-Hsien Yeh, Rachel H. Hsu, Rajat Gupta, Min Zhang, Perla J. Rodriguez, Chang Seok Lee, Baiba Kurins Gillard, Karl‐Dimiter Bissig et al. · 2017 · Scientific Reports
  91. In Vivo Delivery Systems for Therapeutic Genome Editing
    Luyao Wang, Fangfei Li, Lei Dang, Chao Liang, Chao Wang, Bing He, Jin Liu, Defang Li, Xiaohao Wu, Xuegong Xu et al. · 2016 · International Journal of Molecular Sciences
  92. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid
    Qiao Tang, Ji Liu, Ying Yan Jiang, Meining Zhang, Lanqun Mao, Ming Wang · 2019 · ACS Applied Materials & Interfaces
  93. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges
    Lang Yi, Jinming Li · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  94. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
    Sumitava Dastidar, Simon Ardui, Kshitiz Singh, Debanjana Majumdar, Nisha Nair, Yanfang Fu, Deepak Reyon, Ermira Samara-Kuko, M Gerli, Arnaud F. Klein et al. · 2018 · Nucleic Acids Research
  95. In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance
    Yue Zhang, Song Shen, Gui Zhao, Cong‐Fei Xu, Houbing Zhang, Ying‐Li Luo, Zhiting Cao, Jia Yu Shi, Zhibin Zhao, Zhe‐Xiong Lian et al. · 2019 · Biomaterials
  96. Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing
    Qiubing Chen, Ying Zhang, Hao Yin · 2020 · Advanced Drug Delivery Reviews
  97. Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
    Conway, Anthony, Mendel, Matthew, Kim, Kenneth, McGovern, Kyle, Boyko, Alisa, Zhang, Lei, Miller, Jeffrey C., DeKelver, Russell C., Paschon, David E., Mui, Barbara L. et al. · 2019 · Molecular Therapy
  98. History of Polymeric Gene Delivery Systems
    Peng Zhang, Ernst Wagner · 2017 · Topics in Current Chemistry
  99. HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
    Yeh‐Hsing Lao, Mingqiang Li, Madeleine A. Gao, Dan Shao, Chun‐Wei Chi, Dantong Huang, Syandan Chakraborty, Tzu‐Chieh Ho, Weiqian Jiang, Hongxia Wang et al. · 2018 · Advanced Science
  100. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
    Ian P. Winters, Shin‐Heng Chiou, Nicole K. Paulk, Christopher D. McFarland, Pranav V. Lalgudi, Rosanna K. Ma, Leszek Lisowski, Andrew J. Connolly, Dmitri A. Petrov, Mark A. Kay et al. · 2017 · Nature Communications